Applying interventions designed to reduce and manage the symptoms of substance use disorders.
Treatment
Sustained Opioid Antagonism Modulates Striatal Sensitivity to Baby Schema in Opioid Use Disorder
Highlights First fMRI study on the effects of naltrexone on social motivation in opioid-addicted patients. Extended release naltrexone modulates brain response to the level of cuteness in baby portraits. Reduction in craving for opioids is...
Duration of Therapy – Does It Matter?
Highlights Planned duration of therapy not associated with outcome in use of alcohol Actual attended sessions of therapy not associated with outcome in use of alcohol Frequency of research assessments significantly associated with use of...
Webinar: How to Deliver Effective Opioid Substitute Treatment in Prisons
The Substance Misuse Management in General Practice (SMMGP) is hosting a free webinar on Monday the 10th of December at 7 pm.
The Global Drug Survey for 2019
The Global Drug Survey for 2019 (GDS2019) was launched on the 29th of October.
European Action for Employment in Recovery
A new European project has been developed to provide individuals in recovery from substance use in Scotland the opportunity to a part in a work and learning experience in another European country. The European Action for Employment in...
Self‐Medication with Alcohol or Drugs for Mood and Anxiety Disorders
Substance use is one way that people deal with the difficult symptoms present in mood and anxiety disorders. As people become more reliant on the effects of the substances to relieve distress the use can develop into dependence. Self...
The VI International Conference on Novel Psychoactive Substances
The VI International Conference on Novel Psychoactive Substances (NPS) will be held on 8th – 9th April 2019 at the University of Maastricht in the Netherlands.
The conference offers the opportunity to share knowledge and strengthen collaboration on NPS among multidisciplinary professionals at the international level.
The key objectives of the event are:
Comorbid Opioid Use is Undertreated among Forensic Patients with Schizophrenia
Abstract Background Substance use disorders are associated with poorer clinical outcomes in patients with schizophrenia. There is no specific treatment for amphetamine or cannabis use disorder, but methadone and buprenorphine are used as...
The International Consortium of Universities for Drug Demand Reduction (ICUDDR) Annual Conference
The International Consortium of Universities for Drug Demand Reduction (ICUDDR) is holding its 4th annual conference on July 22nd & 23rd, 2019 in Cusco, Peru.
